Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

Author:

Abruzzo G K1,Flattery A M1,Gill C J1,Kong L1,Smith J G1,Krupa D1,Pikounis V B1,Kropp H1,Bartizal K1

Affiliation:

1. Merck Research Laboratories, Rahway, New Jersey 07065-0900, USA.

Abstract

The activities of the water-soluble pneumocandin derivatives L-733560, L-705589, and L-731373 were evaluated in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis and were compared with those of commercially available antifungal agents. Pneumocandins are inhibitors of 1,3-beta-D-glucan synthesis. In the aspergillosis model, L-733560 and L-705589 significantly prolonged the survival of DBA/2N mice challenged intravenously with Aspergillus fumigatus conidia. L-733560 and L-705589 exhibited efficacies comparable to that of amphotericin B (AMB) with 90% effective doses of 0.48, 0.12, and 0.36 mg/kg of body weight, respectively. Two mouse models of disseminated candidiasis were used to evaluate these compounds. In both models, mice were challenged intravenously with Candida albicans. In a C. albicans survival model with DBA/2N and CD-1 mice, the efficacy of L-733560 was comparable to that of AMB, while L-731373 and L-705589 were somewhat less active. In a previously described C. albicans target organ kidney assay, the pneumocandin analogs and AMB at doses of > or = 0.09 mg/kg were effective in sterilizing kidneys, while fluconazole and ketoconazole were considerably less active and did not sterilize kidneys when they were used at concentrations of < or = 100 mg/kg. Although orally administered L-733560 showed activity in both candidiasis models, its efficacy was reduced compared with that of parenterally administered drug. In a disseminated cryptococcosis mouse model that measures the number of CFU of Cryptococcus neoformans per gram of brain and spleen, L-733560 at 10 mg/kg was ineffective in reducing the counts in organs, while AMB at 0.31 mg/kg sterilized the organs. These results indicate that the pneumocandins may be beneficial as potent parenterally administered therapeutic agents for disseminated aspergillosis and candidiasis.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference28 articles.

1. Abruzzo G. K. A. Flattery C. Gill J. Smith H. Kropp and K. Bartizal. 1993. Evaluation of water soluble lipopeptides in a mouse model of disseminated aspergillosis abstr. 355 p. 184. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology Washington D.C.

2. Pneumocandin antifungal lipopeptides. The phenolic hydroxyl is required for 1,3-~-D-glucan synthesis inhibition;Balkovec J. M.;Bioorg. Med. Chem. Lett.,1993

3. Bartizal K. G. Abruzzo and D. Schmatz. 1993. The pneumocandins: biological activity of the pneumocandins p. 421-455. In J. Rippon and R. A. Fromtling (ed.) Cutaneous fungal infections. Marcel Dekker Inc. New York.

4. In vitro antifungal activities and in vivo efficacies of 1,3-~-D-glucan synthesis inhibitors L-671329, L-646991, tetrahydroechinocandin B, and L-687781, a papulacandin;Bartizal K.;Antimicrob. Agents Chemother.,1992

5. Bartizal K. G. K. Abruzzo A. M. Flattery C. J. Gill J. G. Smith L. Lynch C. Pacholok T. Scott L. Kong D. Krupa and H. Kropp. 1993. Anti-Candida in vivo efficacy of water soluble lipopeptides L-705589 L-731373 and L-733560 abstr. 353 p. 184. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology Washington D.C.

Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Triterpenoids;Reference Module in Biomedical Sciences;2021

2. Creation, characterization and utilization of Cryptococcus neoformans mutants sensitive to micafungin;Current Genetics;2017-05-30

3. Clinical Pharmacokinetics of Inhaled Antimicrobials;Clinical Pharmacokinetics;2015-03-04

4. Biochemistry;Cryptococcus neoformans;2014-04-30

5. Discovery and Development of Caspofungin (CANCIDAS): Concept to Clinic;Natural Products;2014-03-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3